IL-10 exacerbates xenogeneic GVHD by inducing massive human T cell expansion

被引:24
作者
Abraham, Sojan [1 ]
Choi, Jang-gi [1 ]
Ye, Chunting [1 ]
Manjunath, N. [1 ]
Shankar, Premlata [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci,Ctr Excellence Infect Dis, El Paso, TX 79905 USA
关键词
GVHD; IL-10; PBMCs; NSG mice; BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; CYTOKINE PRODUCTION; B-CELLS; INTERLEUKIN-10; APOPTOSIS; SURVIVAL; GAMMA; EXPRESSION; RECEPTOR;
D O I
10.1016/j.clim.2014.11.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although patients with GVHD have elevated serum levels of IL10, whether its role is protective or pathogenic remains unclear. Here, we used a humanized mouse model to study the role of IL-10 in GVHD. When human PBMCs were engrafted in NOD-scid IL2r gamma c(null) mice expressing human IL-10, the T cells underwent massive expansion resulting in lethality by day 21, whereas control mice survived for at least 40 days. Histopathology of the liver showed extensive mononuclear cell infiltration in IL-10 expressing but not in control mice. Corresponding to their aggressiveness, the T cells in the IL-10 group exhibited predominantly an effector memory phenotype (CD45RO(+)CD27(-) while in control mice, the T cells were of transitional memory phenotype (CD45RO(+)CD27(+)). Further, IL-10 receptor blocking antibody was able to protect the animals from GVHD. Since our results demonstrate a direct pathogenic role for IL-10, blockade of IL-10 signaling may provide a therapeutic option for GVHD. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 26 条
  • [1] Long-Term Engraftment of Human Natural T Regulatory Cells in NOD/SCID IL2rγcnull Mice by Expression of Human IL-2
    Abraham, Sojan
    Pahwa, Rajendra
    Ye, Chunting
    Choi, Jang-gi
    Pahwa, Savita
    Jaggaiahgari, Shashidhar
    Raut, Ashwin
    Chen, Shuiping
    Manjunath, N.
    Shankar, Premlata
    [J]. PLOS ONE, 2012, 7 (12):
  • [2] Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγnull Mice Display a T-Effector Memory Phenotype
    Ali, Niwa
    Flutter, Barry
    Rodriguez, Robert Sanchez
    Sharif-Paghaleh, Ehsan
    Barber, Linda D.
    Lombardi, Giovanna
    Nestle, Frank O.
    [J]. PLOS ONE, 2012, 7 (08):
  • [3] IL-10 mediation of activation-induced Th1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis
    Ayala, A
    Chung, CS
    Song, GY
    Chaudry, IH
    [J]. CYTOKINE, 2001, 14 (01) : 37 - 48
  • [4] Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses
    Berg, DJ
    Davidson, N
    Kuhn, R
    Muller, W
    Menon, S
    Holland, G
    ThompsonSnipes, L
    Leach, MW
    Rennick, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) : 1010 - 1020
  • [5] Interleukin-10 dose-dependent regulation of CD4+ and CD8+ T cell-mediated graft-versus-host disease
    Blazar, BR
    Taylor, PA
    Panoskaltsis-Mortari, A
    Narula, SK
    Smith, SR
    Roncarolo, MG
    Vallera, DA
    [J]. TRANSPLANTATION, 1998, 66 (09) : 1220 - 1229
  • [6] INTERLEUKIN-10 ADMINISTRATION DECREASES SURVIVAL IN MURINE RECIPIENTS OF MAJOR HISTOCOMPATIBILITY COMPLEX DISPARATE DONOR BONE-MARROW GRAFTS
    BLAZAR, BR
    TAYLOR, PA
    SMITH, S
    VALLERA, DA
    [J]. BLOOD, 1995, 85 (03) : 842 - 851
  • [7] DEWAALMALEFYT R, 1991, J EXP MED, V174, P915
  • [8] DING L, 1992, J IMMUNOL, V148, P3133
  • [9] IL-10 Directly Activates and Expands Tumor-Resident CD8+ T Cells without De Novo Infiltration from Secondary Lymphoid Organs
    Emmerich, Jan
    Mumm, John B.
    Chan, Ivan H.
    LaFace, Drake
    Truong, Hoa
    McClanahan, Terrill
    Gorman, Daniel M.
    Oft, Martin
    [J]. CANCER RESEARCH, 2012, 72 (14) : 3570 - 3581
  • [10] FIORENTINO DF, 1991, J IMMUNOL, V146, P3444